Chison Medical Technologies Co., Ltd. (SHA:688358)
China flag China · Delayed Price · Currency is CNY
32.31
+0.49 (1.54%)
Mar 10, 2026, 10:44 AM CST

SHA:688358 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
447.35468.13480.89375.69394.91
Other Revenue
-0.572.955.162.9
447.35468.7483.84380.84397.81
Revenue Growth (YoY)
-4.55%-3.13%27.05%-4.26%19.43%
Cost of Revenue
-196.94208.34160.6178.89
Gross Profit
447.35271.75275.5220.24218.92
Selling, General & Admin
-92.6384.2681.8476.15
Research & Development
-79.6377.0777.8872.29
Other Operating Expenses
319.86-2.68-3.43-4.3-2.49
Operating Expenses
319.86171.29161.48154.02146.68
Operating Income
127.49100.47114.0266.2272.24
Interest Expense
--0.38-0.36-0.11-0.07
Interest & Investment Income
-37.3229.616.4319.59
Currency Exchange Gain (Loss)
-10.485.4926.13-6.02
Other Non Operating Income (Expenses)
1.7-0.63-0.38-0.38-0.37
EBT Excluding Unusual Items
129.19147.26148.36108.2985.37
Gain (Loss) on Sale of Investments
-0.172.93-1.370.43
Gain (Loss) on Sale of Assets
-4.612.96-0.530.26
Asset Writedown
----0.51-1.59
Other Unusual Items
-4.87.949.2210.08
Pretax Income
129.19156.85162.19115.13124.54
Income Tax Expense
12.5616.3415.719.2912.07
Net Income
116.63140.51146.48105.84112.47
Net Income to Common
116.63140.51146.48105.84112.47
Net Income Growth
-16.99%-4.08%38.40%-5.89%12.88%
Shares Outstanding (Basic)
112112110113112
Shares Outstanding (Diluted)
112112110113112
Shares Change (YoY)
0.57%1.25%-2.19%0.11%0.79%
EPS (Basic)
1.041.261.330.941.00
EPS (Diluted)
1.041.261.330.941.00
EPS Growth
-17.46%-5.26%41.49%-6.00%12.00%
Free Cash Flow
-131.8351.911.530.78
Free Cash Flow Per Share
-1.180.470.100.01
Dividend Per Share
-1.0000.8000.7000.357
Dividend Growth
-25.00%14.29%96.02%-37.50%
Gross Margin
100.00%57.98%56.94%57.83%55.03%
Operating Margin
28.50%21.44%23.57%17.39%18.16%
Profit Margin
26.07%29.98%30.28%27.79%28.27%
Free Cash Flow Margin
-28.13%10.73%3.03%0.19%
EBITDA
138.75111.73125.6878.381.53
EBITDA Margin
31.02%23.84%25.97%20.56%20.50%
D&A For EBITDA
11.2611.2611.6612.079.29
EBIT
127.49100.47114.0266.2272.24
EBIT Margin
28.50%21.44%23.57%17.39%18.16%
Effective Tax Rate
9.72%10.42%9.69%8.07%9.69%
Revenue as Reported
-468.7483.84380.84397.81
Advertising Expenses
-5.273.382.644.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.